A Phase II Trial to Evaluate the Safety and Tolerability of Nebulised Amphotericin B Lipid Complex (ABELCET®) in the Prophylaxis of Invasive Pulmonary Aspergillosis During Prolonged Neutropenia in Paediatric Patients With Acute Leukaemia
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Amphotericin B liposomal (Primary)
- Indications Aspergillosis
- Focus Adverse reactions
- 02 Mar 2015 New trial record